Rockwell Medical (RMTI)
(Delayed Data from NSDQ)
$3.92 USD
-0.48 (-10.91%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $3.93 +0.01 (0.26%) 4:56 PM ET
1-Strong Buy of 5 1
C Value A Growth F Momentum C VGM
Rockwell Medical (RMTI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.50 | $9.00 | $6.00 | 70.45% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Rockwell Medical comes to $7.50. The forecasts range from a low of $6.00 to a high of $9.00. The average price target represents an increase of 70.45% from the last closing price of $4.40.
Analyst Price Targets (2 )
Broker Rating
Rockwell Medical currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, two are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/16/2024 | Maxim Group | Anthony V Vendetti | Strong Buy | Strong Buy |
8/12/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 2 |
Average Target Price | $7.50 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 0.01 |
RMTI FAQs
Rockwell Medical, Inc. (RMTI) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Rockwell Medical, Inc. (RMTI) is $7.50. The current on short-term price targets is based on 1 reports.
The forecasts for Rockwell Medical, Inc. (RMTI) range from a low of $6 to a high of $9. The average price target represents a increase of $70.45 from the last closing price of $4.40.
The current UPSIDE for Rockwell Medical, Inc. (RMTI) is 70.45%
Based on short-term price targets offered by two analysts, the average price target for Rockwell Medical comes to $7.50. The forecasts range from a low of $6.00 to a high of $9.00. The average price target represents an increase of 70.45% from the last closing price of $4.40.